Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Mast-Cell-Derived RANKL in Ovariectomy-Induced Bone Loss in Mice. | Int J Mol Sci | 2023 | 37298085 | PubTator, text mining | PubMed |
| How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors. | Cancers (Basel) | 2023 | 37296881 | PubTator, text mining | PubMed |
| The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data. | Cell Biosci | 2023 | 37291676 | PubTator, text mining | PubMed |
| Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing. | Front Immunol | 2023 | 37287976 | PubTator, text mining | PubMed |
| Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer. | Biomark Res | 2023 | 37280670 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal changes in cell heterogeneity during progression of human tendinopathy. | BMC Biol | 2023 | 37280595 | PubTator, text mining | PubMed |
| Deciphering the single-cell transcriptome network in keloids with intra-lesional injection of triamcinolone acetonide combined with 5-fluorouracil. | Front Immunol | 2023 | 37275903 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing analysis reveals enhanced non-canonical neurotrophic factor signaling in the subacute phase of traumatic brain injury. | CNS Neurosci Ther | 2023 | 37269057 | PubTator, text mining | PubMed |
| Using human induced pluripotent stem cell-derived liver cells to investigate the mechanisms of liver fibrosis in vitro. | Biochem Soc Trans | 2023 | 37264940 | PubTator, text mining | PubMed |
| The role of m6A methylation in therapy resistance in cancer. | Mol Cancer | 2023 | 37264402 | PubTator, text mining | PubMed |
| Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools. | J Natl Cancer Inst | 2023 | 37260165 | PubTator, text mining | PubMed |
| Versatility of Liposomes for Antisense Oligonucleotide Delivery: A Special Focus on Various Therapeutic Areas. | Pharmaceutics | 2023 | 37242677 | PubTator, text mining | PubMed |
| Gene Expression Changes in Cytokine and Chemokine Receptors in Association with Melanoma Liver Metastasis. | Int J Mol Sci | 2023 | 37240247 | PubTator, text mining | PubMed |
| Comparative Transcriptomic Analysis of Three Common Liver Cell Lines. | Int J Mol Sci | 2023 | 37240140 | PubTator, text mining | PubMed |
| Role of Midkine in Cancer Drug Resistance: Regulators of Its Expression and Its Molecular Targeting. | Int J Mol Sci | 2023 | 37240085 | PubTator, text mining | PubMed |
| Impacts of Mir146a Genotypes on Bladder Cancer Risk in Taiwan. | Biomedicines | 2023 | 37239070 | PubTator, text mining | PubMed |
| Implication of the PTN/RPTPβ/ζ Signaling Pathway in Acute Ethanol Neuroinflammation in Both Sexes: A Comparative Study with LPS. | Biomedicines | 2023 | 37238989 | PubTator, text mining | PubMed |
| Abnormal glycosylation in glioma: related changes in biology, biomarkers and targeted therapy. | Biomark Res | 2023 | 37231524 | PubTator, text mining | PubMed |
| Machine learning-based glycolysis-associated molecular classification reveals differences in prognosis, TME, and immunotherapy for colorectal cancer patients. | Front Immunol | 2023 | 37228620 | PubTator, text mining | PubMed |
| Plasma protein changes reflect colorectal cancer development and associated inflammation. | Front Oncol | 2023 | 37228491 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=25